Drug Profile
Ursodoxicoltaurine - Mitsubishi Pharma Corporation
Alternative Names: Taurolite; Tauroursodeoxycholate sodium; Tauroursodeoxycholic acid; Taurursodiol; TUDCA; Tudcabil; UR 906; UrsodeoxycholyltaurineLatest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Mitsubishi Pharma Corporation
- Class Amides; Antivirals; Cholic acids; Gallstone therapies; Hepatoprotectants; Small molecules; Sulfonic acids
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
Most Recent Events
- 12 Oct 2001 No-Development-Reported for Liver disorders in Japan (Injection)
- 16 Nov 1999 Tokyo Tanabe has been acquired by Mitsubishi Chemical